Lori A. Henderson, Ph.D.

Dr. Henderson heads CTEP’s Clinical Grants and Contracts Branch. She directs programmatic activities for CGCB’s portfolio of clinical trials and research programs and manages CGCB's hematology-oncology portfolio. Dr. Henderson also supports large research network initiatives and databases including BMT-CTN, CIBMTR, CCSS, and PDXNet 2.0. She leads the NCI Clinical Trials Stewardship Committee, which reviews and updates NCI's procedures and operations to ensure proper oversight and monitoring of NCI-funded awards with clinical trials.

Dr. Henderson joined NCI in 2011 as a program director in DCTD’s Cancer Imaging Program. She oversees NCI-funded clinical imaging trials focused on the diagnosis and treatment of a wide range of solid tumors. Before joining the government, she was a senior scientist and global project leader at Novozymes North America (Novo Nordisk). She obtained her Ph.D. in polymer science (chemistry-engineering majors) from the University of Massachusetts, Lowell. This laid the groundwork for her understanding of biomaterials and biological processes for health-related research at the molecular and cellular levels.